ORIC PHARMACEUTICALS
ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s lead product candidate,ORIC-101, is a potent and selective small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across a variety of solid tumors. ORIC’s second product candidate, ORIC-533, is an orally bioavailable small molecule inhibitor of CD73, a key node i... n the adenosine pathway believed to play a central role in resistance to chemotherapy- and immunotherapy-based treatment regimens. Beyond these two product candidates, ORIC is also developing multiple precision medicines targeting other hallmark cancer resistance mechanisms. ORIC’s scientific founders, Charles Sawyers, MD, and Scott Lowe, PhD, have long records of discovering novel targets in cancer that have led to innovative treatments.
ORIC PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.oricpharma.com
Total Employee:
101+
Status:
Active
Contact:
(650)388-5600
Email Addresses:
[email protected]
Total Funding:
173 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Acasti Pharma
Acasti Pharma is an emerging biopharmaceutical company.
Acerus Pharmaceuticals
Acerus Pharmaceuticals Corporation is a Canadian-based specialty pharmaceutical company.
Alltrna
Alltrna is the creator of a tRNA platform that aims to decipher tRNA biology and pioneer therapies for disease treatment.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Basilea Pharmaceutica
Basilea Pharmaceutica Ltd. is a commercial stage biopharmaceutical company.
Biocytogen
Biopharmaceutical company.
Bond Biosciences
Bond Biosciences is a biopharmaceutical company
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company.
FastFarma
FastFarma operates as a digital pharmacy.
Purple Biotech
Purple Biotech is an innovative biopharmaceutical drug development company.
MailMyPrescriptions.com
Online Pharmacy | America's First Wholesale Pharmacy Service
OncoQuest
OncoQuest is a Edmonton-based biopharmaceutical company.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Zhaoke Ophthalmology Pharmaceutical
Zhaoke Ophthalmology Pharmaceutical is a Pharmaceutical platform.
ZWI Therapeutics, Inc.
ZWI Therapeutics is a biotech company developing a new polymer to reduce immunogenicity and aid pharmacokinetics of protein therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Taiho Ventures
Taiho Ventures investment in Series D - ORIC Pharmaceuticals
Casdin Capital
Casdin Capital investment in Series D - ORIC Pharmaceuticals
Correlation Ventures
Correlation Ventures investment in Series D - ORIC Pharmaceuticals
Invus
Invus investment in Series D - ORIC Pharmaceuticals
Irving Investors
Irving Investors investment in Series D - ORIC Pharmaceuticals
Memorial Sloan - Kettering Cancer Center
Memorial Sloan - Kettering Cancer Center investment in Series D - ORIC Pharmaceuticals
OrbiMed
OrbiMed investment in Series D - ORIC Pharmaceuticals
Hartford HealthCare Endowment
Hartford HealthCare Endowment investment in Series D - ORIC Pharmaceuticals
City Hill Ventures
City Hill Ventures investment in Series D - ORIC Pharmaceuticals
Topspin Partners
Topspin Partners investment in Series D - ORIC Pharmaceuticals
Official Site Inspections
http://www.oricpharma.com Semrush global rank: 3.82 M Semrush visits lastest month: 3.48 K
- Host name: 249.28.212.35.bc.googleusercontent.com
- IP address: 35.212.28.249
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "ORIC Pharmaceuticals"
About - ORIC Pharmaceuticals
Resistance limits the efficacy of otherwise significant cancer treatment breakthroughs, regardless of modality. Our ambition at ORIC is to discover and develop innovative therapies that benefit patients with cancer, including by …See details»
Patients - ORIC Pharmaceuticals
[email protected] (650) 388-5600 . 1. 1. Working to address key unmet needs across a number of cancer types. Despite many recent advances in cancer treatments with …See details»
ORIC Pharmaceuticals - Crunchbase Company Profile …
Contact Email [email protected]. Phone Number (650)388-5600. ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s lead …See details»
ORIC Pharmaceuticals Inc. | LinkedIn
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include ...See details»
Oric Pharmaceuticals - Overview, News & Similar companies
Jun 7, 2024 Oric Pharmaceuticals contact info: Phone number: (650) 388-5600 Website: www.oricpharma.com What does Oric Pharmaceuticals do? ORIC Pharmaceuticals is a …See details»
ORIC Pharmaceuticals Provides Corporate Update and Highlights …
For more information, please go to www.oricpharma.com, and follow us on Twitter or LinkedIn. Cautionary Note Regarding Forward-Looking Statements. This press release contains forward …See details»
ORIC Pharmaceuticals Reports First Quarter 2023 Financial Results …
For more information, please go to www.oricpharma.com, and follow us on Twitter or LinkedIn. Cautionary Note Regarding Forward-Looking Statements This press release contains forward …See details»
Careers - ORIC Pharmaceuticals
ORIC® is a science-driven, clinical stage company dedicated to discovering and developing novel therapies to improve patients’ lives by Overcoming Resistance In Cancer. We offer a collaborative, empowering culture that gives scientists …See details»
ORIC Pharmaceuticals - Craft
ORIC is a pharmaceutical company dedicated to discovering and developing therapies towards overcoming resistance in cancer. It offers a small molecule antagonist of the glucocorticoid …See details»
ORIC® Pharmaceuticals to Participate in Upcoming Investor …
SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on …See details»
ORIC Pharmaceuticals, Inc. (ORIC) - Yahoo Finance
44.98. +3.38%. PRLD Prelude Therapeutics Incorporated. 0.9487. -1.91%. Find the latest ORIC Pharmaceuticals, Inc. (ORIC) stock quote, history, news and other vital information to help you …See details»
ORIC Pharmaceuticals Provides Corporate Update and Highlights …
Jan 9, 2023 ORIC Pharmaceuticals. Initial Phase 1b data for three ongoing clinical trials expected in second half of 2023: ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2 …See details»
about - ORIC Pharmaceuticals
©ORIC Pharmaceuticals, Inc. All rights reserved. ORIC and the stylized ORIC mark are registered trademarks of ORIC Pharmaceuticals, Inc.See details»
ORIC Pharmaceuticals Provides Corporate Update and
Jan 9, 2023 ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming Milestones. January 09, 2023 08:00 ET | Source: ORIC Pharmaceuticals. Follow. Initial Phase …See details»
ORIC Pharmaceuticals, Inc. (ORIC) - Stock Analysis
Nov 19, 2024 Website https://www.oricpharma.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 9 analysts, the average …See details»
ORIC Pharmaceuticals Provides Corporate Update and Highlights …
Jan 11, 2021 For more information, please go to www.oricpharma.com. Cautionary Note Regarding Forward-Looking Statements. This press release contains forward-looking …See details»
Working At ORIC Pharmaceuticals: Company Overview and Culture …
Mar 14, 2024 oricpharma.com. Organization Type. Public. Social Media. ORIC Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to improving patients' lives by …See details»
ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2021 ...
Mar 21, 2022 To participate in the conference call, please dial (833) 651-0991 (domestic) or (918) 922-6080 (international) and refer to conference ID 8637367. A live webcast and audio …See details»